NanoEcho AB (publ)

NANECH · ST · Healthcare / Biotechnology

0.013SEK-0.01 (-37.50%)

Price History

Full chart

Market Stats

Previous Close0.0208

Open0.0198

Day Range0.0128 – 0.0204

52-Week Range0.019 – 0.10

Volume5.91M

Market Cap10.25M

P/E (TTM)0.00

Forward P/E0.00

EPS-0.04

Dividend Yield0.00%

Beta0.63

50-Day Avg0.0292

200-Day Avg0.0418

About

NanoEcho AB (publ) engages in developing a new diagnostic method to determine the spread of rectal cancer to nearby lymph nodes. The company was incorporated in 2013 and is headquartered in Lund, Sweden.

Company Details

SectorHealthcare
IndustryBiotechnology
CEOMr. Bjorn Larsson
Employees5
HeadquartersScheelevägen 19, Lund, Sweden, 223 63, Sweden
Websitehttps://nanoecho.se

Leadership

Mr. Bjorn LarssonActing CEO and Director · b. 1965
Ms. Fata MrsicChief Financial Officer
Mr. Nils LofgrenChief Technology Officer

Financials

Income Statement

Currency: SEK	2022-12-31	2023-12-31	2024-12-31	2025-12-31
Total Revenue	0	0	0	488.00K
Cost of Revenue	-	0	-4.61M	0
Gross Profit	-	0	4.61M	488.00K
Gross Margin	-	-	-	100.00%
Operating Expense	-	14.85M	19.99M	15.79M
Operating Income	-16.70M	-14.85M	-15.38M	-15.31M
Operating Margin	-	-	-	-3136.68%
EBITDA	-16.70M	-14.43M	-14.94M	-14.52M
EBITDA Margin	-	-	-	-2975.00%
Net Income	-16.61M	-14.43M	-15.15M	-15.65M
Net Income Margin	-	-	-	-3207.79%
Interest Expense	-	1.00K	4.00K	993.00K
Interest Expense % of Total Revenue	-	-	-	203.48%

Balance Sheet

Currency: SEK	2022-12-31	2023-12-31	2024-12-31	2025-12-31
Total Assets	14.39M	21.78M	33.26M	18.42M
Total Liabilities	2.89M	3.29M	14.78M	3.68M
Total Equity	11.50M	18.50M	18.47M	14.73M
Cash	-	14.08M	14.65M	2.13M
Net Debt	2.89M	3.29M	-	-

Cash Flow

Currency: SEK	2022-12-31	2023-12-31	2024-12-31	2025-12-31
Operating Cash Flow	-15.92M	-13.88M	-14.60M	-16.16M
Capital Expenditure	0	2.71M	7.83M	399.00K
Free Cash Flow	-15.92M	-16.58M	-22.43M	-16.56M
FCF to OCF	100.00%	119.49%	153.60%	102.47%

Key Statistics & Ratios

Market Cap10.25M

Enterprise Value9.82M

Trailing P/E0.00

Forward P/E0.00

Price / Sales10.52

Price / Book0.84

EPS-0.04

Book Value0.03

Revenue (TTM)974.00K

Gross Profit (TTM)974.00K

EBITDA-14.43M

Profit Margin0.00%

Operating Margin-718.48%

Return on Equity-83.91%

Return on Assets-42.79%

Shares Outstanding470.20M

Shares Float414.79M

Beta0.63

Dividend Yield0.00%

Dividend Rate0.00

Payout Ratio0.00%